Re-thinking race and geography in multiple sclerosis
D Ontaneda, L Amezcua - Multiple Sclerosis Journal, 2024 - journals.sagepub.com
Finally, perhaps one of the most significant problems not only of MS, but of health sciences
in general, is how we should move forward with the categorization of race and ethnicity …
in general, is how we should move forward with the categorization of race and ethnicity …
Safety, tolerability, and efficacy of diroximel fumarate in a cohort of Black patients with multiple sclerosis from the phase 3 EVOLVE-MS-1 study
SF Hunter, JW Lindsey, B Osborne, B Schreiber… - Multiple Sclerosis and …, 2024 - Elsevier
Background Multiple sclerosis (MS) has not been well studied in racial and ethnic minorities,
as these populations are typically underrepresented in clinical trials. Black or African …
as these populations are typically underrepresented in clinical trials. Black or African …
Pacjentka z nowo zdiagnozowaną rzutowo-remisyjną postacią stwardnienia rozsianego, u której zastosowano leczenie fumaranem dimetylu de novo–opis przypadku
K Kubicka-Bączyk, M Adamczyk-Sowa - MS Report, 2024 - journalsmededu.pl
Obecnie w leczeniu rzutowo-remisyjnej postaci stwardnienia rozsianego dysponujemy
kilkunastoma lekami wpływającymi na przebieg choroby o różnej skuteczności i profilu …
kilkunastoma lekami wpływającymi na przebieg choroby o różnej skuteczności i profilu …